{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:03:43Z","timestamp":1780387423865,"version":"3.54.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To analyse outcomes of supraventricular tachycardia (SVT) ablations performed within a prospective German Ablation Quality Registry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Data from 12\u00a0566 patients who underwent catheter ablation of SVT between January 2007 and January 2010 to treat atrial fibrillation (AFIB, 37.2% of procedures), atrial flutter (AFL, 29.9%), atrioventricular nodal re-entrant tachycardia (AVNRT, 23.2%), atrioventricular re-entrant tachycardia (6.3%), and focal atrial tachycardia (AT, 3.4%) were prospectively collected. Patients were followed for at least 1 year. The periprocedural success rate was 96.3%, ranging from 84.3% (focal AT) to 98.9% (AVNRT). Kaplan\u2013Meier mortality estimate at 1 year was 1.4% overall, and as high as 2.6% in the AFL group and 2.8% in the focal AT group. Recurrence of ablated or another symptomatic SVT was observed in 3783 (32.6%) of patients, ranging from 17.2% (AVNRT) to 45.6% (AFIB). Repeat ablation was performed in 12.0% of patients. After 1 year, 74.1% of survivors perceived ablation therapy as successful, 15.7% as partly successful, and 9.6% as unsuccessful. Even in those patients with arrhythmia recurrence, 76.0% perceived ablation as successful or partly successful and 89.6% would still undergo repeat ablation in the same institution.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Ablation therapy for SVT is a safe procedure bringing symptomatic improvement and satisfaction to three quarters of patients after 1 year. Even in patients with arrhythmia recurrence, a high satisfaction level and adherence to the ablating institution could be documented. Strikingly high mortality and stroke rates in follow-up were observed in AFL patients, who apparently need consistent long-term anticoagulation and more medical attention.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehx101","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T12:14:18Z","timestamp":1488456858000},"page":"1317-1326","source":"Crossref","is-referenced-by-count":79,"title":["Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry"],"prefix":"10.1093","volume":"38","author":[{"given":"Johannes","family":"Brachmann","sequence":"first","affiliation":[{"name":"1Department of Cardiology, Angiology, and Pneumology, Second Medical Clinic, Coburg Hospital, Coburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lewalter","sequence":"additional","affiliation":[{"name":"2Department of Medicine-Cardiology and Intensive Care, Hospital Munich-Thalkirchen, Am Isarkanal 36, 81379 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Kuck","sequence":"additional","affiliation":[{"name":"3Department of Cardiology, Asklepios Klinik St Georg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Andresen","sequence":"additional","affiliation":[{"name":"4Department of Cardiology and Internal Medicine, Vivantes Klinikum Am Urban, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Willems","sequence":"additional","affiliation":[{"name":"5Department of Electrophysiology, University Heart Center Hamburg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"Spitzer","sequence":"additional","affiliation":[{"name":"6Praxisklinik Herz und Gefaesse, Dresden, Germany and Institute of Medical Technology Brandenburg University of Technology Cottbus \u2013 Senftenberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Straube","sequence":"additional","affiliation":[{"name":"7Heart Center Munich-Bogenhausen, Munich Municipal Hospital Group, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burghard","family":"Schumacher","sequence":"additional","affiliation":[{"name":"8Herz- und Gefaessklinik, Bad Neustadt\/Saale, Germany (old institution), Westpfalz-Klinikum GmbH, Kaiserslautern, Germany (new institution)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[{"name":"9Division of Electrophysiology, Department of Cardiology and Angiology, University of Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Danilovic","sequence":"additional","affiliation":[{"name":"10Stiftung Institut f\u00fcr Herzinfarktforschung (IHF), Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Thomas","sequence":"additional","affiliation":[{"name":"11Department of Cardiology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hochadel","sequence":"additional","affiliation":[{"name":"10Stiftung Institut f\u00fcr Herzinfarktforschung (IHF), Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Senges","sequence":"additional","affiliation":[{"name":"10Stiftung Institut f\u00fcr Herzinfarktforschung (IHF), Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"2022102518004317600_ehx101-B1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM199902183400707","article-title":"Radio-frequency ablation as treatment for cardiac arrhythmias","volume":"340","author":"Morady","year":"1999","journal-title":"N Engl J Med"},{"key":"2022102518004317600_ehx101-B2","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMct1109977","article-title":"Catheter ablation for atrial fibrillation","volume":"365","author":"Wazni","year":"2011","journal-title":"N Engl J Med"},{"key":"2022102518004317600_ehx101-B3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.1982.03330070039027","article-title":"Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias","volume":"248","author":"Scheinman","year":"1982","journal-title":"Jama"},{"key":"2022102518004317600_ehx101-B4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0735-1097(87)80200-0","article-title":"High frequency alternating current ablation of an accessory pathway in humans","volume":"10","author":"Borggrefe","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"2022102518004317600_ehx101-B5","author":"The EHRA White Book 2014"},{"key":"2022102518004317600_ehx101-B6","first-page":"1493","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2013executive summary. A report of the American college of cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society","volume":"42","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022102518004317600_ehx101-B7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/europace\/eun354","article-title":"Catheter ablation procedures: role of nation-wide registries","volume":"11","author":"Da Costa","year":"2009","journal-title":"Europace"},{"key":"2022102518004317600_ehx101-B8","first-page":"928","article-title":"Spanish Catheter Ablation Registry. 11th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2011)","volume":"65","author":"Diaz-Infante","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"2022102518004317600_ehx101-B9","first-page":"347","article-title":"National Registry on Cardiac Electrophysiology 2009","volume":"30","author":"Ventura","year":"2011","journal-title":"Rev Port Cardiol"},{"key":"2022102518004317600_ehx101-B10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1540-8159.2009.02312.x","article-title":"Five years of catheter ablation procedures in South-Western Europe: meta-analysis of National Registries","volume":"32","author":"Inama","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"2022102518004317600_ehx101-B11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/europace\/eun298","article-title":"Ablation procedures in Sweden during 2007: results from the Swedish Catheter Ablation Registry","volume":"11","author":"Kesek","year":"2009","journal-title":"Europace"},{"key":"2022102518004317600_ehx101-B12","first-page":"108","article-title":"Radiofrequency ablation procedures in Greece: initial experience and results from the national registry 2008-2010","volume":"53","author":"Vassilikos","year":"2012","journal-title":"Hellenic J Cardiol"},{"key":"2022102518004317600_ehx101-B13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022102518004317600_ehx101-B14","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102518004317600_ehx101-B15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/europace\/eus027","article-title":"2012\u2009HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"14","author":"Calkins","year":"2012","journal-title":"Europace"},{"key":"2022102518004317600_ehx101-B16","author":"European Perspectives in Cardiology"},{"key":"2022102518004317600_ehx101-B17","doi-asserted-by":"crossref","first-page":"67B","DOI":"10.1016\/S0828-282X(07)71013-9","article-title":"Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital","volume":"23(Suppl.B)","author":"O'Hara","year":"2007","journal-title":"Can J Cardiol"},{"key":"2022102518004317600_ehx101-B18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/europace\/eum014","article-title":"Elimination of cavotricuspid isthmus conduction by a single ablation lesion: observations from a maximum voltage-guided ablation technique","volume":"9","author":"Posan","year":"2007","journal-title":"Europace"},{"key":"2022102518004317600_ehx101-B19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/hrt.2009.190017","article-title":"Invasive therapy for atrial fibrillation: recent developments in ablation, navigation and mapping technology","volume":"97","author":"Andrikopoulos","year":"2011","journal-title":"Heart"},{"key":"2022102518004317600_ehx101-B20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11886-011-0205-2","article-title":"Atrial fibrillation: update on ablation strategies and technology","volume":"13","author":"Challa","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"2022102518004317600_ehx101-B21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jjcc.2011.06.008","article-title":"Frontier of catheter ablation for atrial fibrillation","volume":"58","author":"Iesaka","year":"2011","journal-title":"J Cardiol"},{"key":"2022102518004317600_ehx101-B22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/erd.10.59","article-title":"A critical appraisal of cardiac ablation technology for catheter-based treatment of atrial fibrillation","volume":"8","author":"Shah","year":"2011","journal-title":"Expert Rev Med Devices"},{"key":"2022102518004317600_ehx101-B23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1540-8167.2011.02252.x","article-title":"\u201cLargest amplitude ablation\u201d is the optimal approach for typical atrial flutter ablation: a subanalysis from the AURUM 8 study","volume":"23","author":"Lewalter","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2022102518004317600_ehx101-B24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.hrthm.2009.06.009","article-title":"Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries","volume":"6","author":"Ellis","year":"2009","journal-title":"Heart Rhythm"},{"key":"2022102518004317600_ehx101-B25","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jacc.2009.02.022","article-title":"Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation","volume":"53","author":"Cappato","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022102518004317600_ehx101-B26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10840-011-9662-1","article-title":"Trends in atrial fibrillation ablation: have we maximized the current paradigms?","volume":"34","author":"Winkle","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"2022102518004317600_ehx101-B27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022102518004317600_ehx101-B28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCEP.111.962100","article-title":"Natural history and long-term outcomes of ablated atrial fibrillation","volume":"4","author":"Hussein","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022102518004317600_ehx101-B29","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1161\/CIRCULATIONAHA.110.946806","article-title":"Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up","volume":"122","author":"Ouyang","year":"2010","journal-title":"Circulation"},{"key":"2022102518004317600_ehx101-B30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jacc.2010.05.061","article-title":"Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?","volume":"57","author":"Weerasooriya","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022102518004317600_ehx101-B31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.CIR.99.2.262","article-title":"Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group","volume":"99","author":"Calkins","year":"1999","journal-title":"Circulation"},{"key":"2022102518004317600_ehx101-B32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/jce.12338","article-title":"One size doesn't fit all: AF ablation, complications, and patients with structural heart disease","volume":"25","author":"Chow","year":"2014","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/38\/17\/1317\/46631429\/eurheartj_38_17_1317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/38\/17\/1317\/46631429\/eurheartj_38_17_1317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T18:32:23Z","timestamp":1666722743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/38\/17\/1317\/3074208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":32,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2017,3,17]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx101","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,1]]},"published":{"date-parts":[[2017,3,17]]}}}